DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
105 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2025-05-31 (thehindubusinessline.com)
Novo Nordisk diabetes / weightloss drug semaglutide locked in a legal tangle with DRL - The Hindu
Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug availability.
Read more
2024-09-21 (economictimes.com)
No observations by US FDA during plant inspection: DRL
Dr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) inspection of its integrated product development organization in Bachupally, Hyderabad, with zero observations.
Read more
2024-01-17 (financialexpress.com)
Dr Reddy's Laboratories eyes mega brand in UK - Healthcare News | The Financial Express
Nicotinell, which is sold in patch, gum and lozenge form, is said to be the second-largest nicotine replacement therapy product globally.Dr Reddy's Laboratories eyes mega brand in UK.
Read more
2017-09-08 (expresspharma.in)
DRL's Visakhapatnam unit gets six observations by German regulator -
The facility's compliance with the CAPA and other applicable regulations will be reviewed again by the regulator by November 2018 for continuation of EU-GMP certification
Read more
2016-02-01 (expresspharma.in)
DRL receives US FDA approval for treatment of acute migraine episodes -
ZEMBRACESymTouch is available as a prefilled, ready-to-use, single-dose disposable autoinjector containing 3 mg of sumatriptan US Food and Drug Administration (US FDA) has approved Dr Reddy's Laboratories (DRL's) ZEMBRACESymTouch (sumatriptan […]
Read more
2015-11-26 (expresspharma.in)
US FDA warns of serious data integrity violations at DRL -
The US Food and Drug Administration has warned DRL over serious data integrity violations, placing all its new applications or supplements under a cloud The US Food and Drug Administration […]
Read more
(bizzbuzz.news)
DRL gets FDA inspection report for Vizag units
Hyderabad: Dr Reddy's Laboratories Ltd on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its formulations manufacturing units at Duvvada in...
Read more
(indiatimes.com)
DRL inks pact with Amgen to market three drugs in India - ET HealthWorld | Pharma
Under the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said today.
Read more